What is this ingredient? Turmeric is the bright yellow root of Curcuma longa, traditionally used as both a culinary spice and a medicinal plant. Its main polyphenol, curcumin, has been widely studied for antioxidant, anti‑inflammatory, and metabolic effects. In liver‑focused research, randomized controlled trials and meta‑analyses in people with non‑alcoholic fatty liver disease (NAFLD) show that curcumin supplementation can meaningfully improve liver enzymes (ALT and AST), reduce hepatic fat on imaging, and favorably influence blood lipids and insulin resistance compared with placebo [0,1,3,8].
Recent placebo‑controlled studies using enhanced or phytosomal curcumin formulations report reductions in liver stiffness, steatosis grades, and markers of oxidative stress and inflammation over 8–24 weeks in NAFLD and metabolic‑associated steatotic liver disease [1,3,5,7]. Collectively, these data support turmeric’s role as a liver‑supportive botanical when used alongside diet and lifestyle measures.
Why include it in this formula? With Milk Thistle Seed Oil Powder, artichoke, kudzu root, dandelion, citrus and green tea powders, plus inulin and sugar alcohols, this product is clearly oriented toward liver and digestive support with an emphasis on antioxidant and metabolic balance. Within that architecture, turmeric is the primary "inflammation and liver‑fat" pillar. Its curcumin content helps modulate oxidative stress and inflammatory pathways in hepatocytes and can reduce liver fat content and improve liver enzymes in clinical NAFLD trials [0,1,3,5,7,8].
By pairing turmeric with milk thistle (hepatocellular support), artichoke and dandelion (bile and lipid metabolism), and polyphenol‑rich citrus and green tea, the formula targets several aspects of the gut–liver axis at once. Prebiotic fibers like inulin further support the microbiome, which interacts with curcumin’s effects on bile acids and metabolic signaling [1,3,5]. Altogether, turmeric helps ensure this milk‑thistle blend doesn’t just nourish the liver structurally, but also addresses the low‑grade inflammation and fat accumulation that commonly challenge modern livers.
References
- [0] Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
- [1] Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE‑assessed systematic review and dose‑response meta‑analysis of randomized controlled trials
- [3] Efficacy and Safety of Phytosomal Curcumin in Non‑Alcoholic Fatty Liver Disease: A Randomized Controlled Trial
- [5] Curcumin for Inflammation Control in Individuals with Type 2 Diabetes Mellitus and Metabolic Dysfunction‑Associated Steatotic Liver Disease: A Randomized Controlled Trial
- [8] The effects of curcumin on the metabolic parameters of non‑alcoholic fatty liver disease: a meta‑analysis of randomized controlled trials